Abstract-This paper described the production of a novel biosynthetic materials using the manufacturing technique of electrospinning for the construction of scaffold for organ replacement. This electrostatic technique uses an electric field to control the deposition of polymer fibres onto a specific substrate to fabricate fibrous polymer constructs composed of fibre diameters ranging from several microns down to 100 nm or less. Two areas of research, in particular, heart valve leaflets and blood vessel will be discussed. Here, a sandwich structure nanofibre mesh was used to construct materials for leaflets of heart valve and blood vessel. In the case of heart valve leaflet, the randomly oriented polyurethane nanofibres were prepared as the first layer, followed by gelatin-chitosan complex layer. Complex nanofibres were initially used to spin on the PU layer with cross orientation to mimic the fibrosa layer. A gelatin and chitosan complex was then spun onto the other side of PU nanofibre mesh to mimic the ventricularis layer. This particular sandwich structure using the PU layer was designed to simulate the mechanical properties of natural tissue. In addition, this design was aimed to provide good biocompatibility and improved cellular environment to assist in adhesion and proliferation. Smooth muscle cells adhered and flattened out onto the surface of the gelatin-chitosan complex as early as 1 day post seeding. There is great potential for this biosynthetic biocompatible nanofibrous material to be developed for various clinical applications.
INTRODUCTION
The key point of the tissue and organ regeneration is to create scaffolds which should take the shape of the targeted organ and possess sufficient porosity to facilitate nutrient transport, cell growth, production of extracellular matrix and finally, integration with the surrounding tissue. Although a lot of research has been conducted in the area of tissue engineering and scaffolds, the ideal or optimal biomaterial, hence, scaffold, is still not available for delicate tissues such as small diameter blood vessel, heart valve leaflet and cornea. Recently, it has been shown that nanofibrous structure improved tissue regeneration in vitro [1] . This is most likely due to the fact that native extracellular matrix (ECM) in tissue is of nanofibrous composite [2] . In this study, the electrospining method has been used to fabricate the biomimetic nanofibrous material for cardiovascular applications. The nanofibrous material comprises of polyurethane (PU) fibres in the order of nanometres, made into a mesh and coated on both sides with a gelatin-chitosan complex. The aim of this investigation was to examine the biocompatibility of the gelatin-chitosan PU nanofibrous material in vitro using smooth muscle cells.
II. MATERIALS AND METHODS

A. Electrospinning of nanofibres
Porcine Gelatin type A (Sigma-Aldrich, Shanghai, China ) and Chitosan (deacetylation degree of 85%, Hedebei Co. Jinan, China) were dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol (HFP)/Trifluoroacetic acid (TFA)(9/1) to give 14% gelatin-chitosan complex solution with gelatin to chitosan ratio of 5 to 2. PU (Tecoflex TPU, Noveon Shanghai Co.,Ltd) was dissolved in DMF/THF(1/1) to give 25% PU solution. PU solution was first spun into nanofibres at high voltage of 22KV and collected on an aluminum foil. The process was continued until the mesh of random nanofibres reached a thickness of 0.1mm. Then, gelatin-chitosan complex nanofibres were spun onto the PU nanofibrous mesh to produce a coating of approximately 0.1mm in thickness of gelation-chitosan complex. This bi-layer composite was then detached from the aluminum foil and turned over so that the other side of the PU surface could be coated. The coating of the gelatin-chitosan complex was repeated as described above, thus, producing a sandwich structure of nanofibrous composite with PU nanofibres as the middle layer and gelatin-chitosan complex as the outer layers. The total thickness of the biosynthetic material is approximately 0.3 mm. The material was then dried in a vacuum oven for 24 h at room temperature to ensure complete evaporation of the solvents. The surface morphology of this composite was observed under SEM microscopy (Jeol JSM-5800LV).
Electrospinning of nanofibres for construction of vital organ replacements B. Seeding of SMCon PU nanofibres
Smooth muscle cells were harvested enzymatically from fresh ovine aorta using dissociation solution consisting of 1 mg/ml collagenase Type 1A (Sigma-Aldrich, St Louis, MO, USA), 2 mg/ml BSA (Bovogen Biologicals, Essendon, VIC, Australia), 0.25 mg/ml soybean trypsin inhibitor and 0.125 mg/ml elastase (Merck Biosciences, Kilsyth, VIC, Australia) dissolved in Hank's Balanced Salt Solution (Gibco, Invitrogen Corp, Carlsbad, CA, USA). The digested tissue was centrifuged at 1200 rpm for 5 min and cell pellet was resuspended and maintained in Dulbecco's Modified Eagle Medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS), 1% of 10,000 U/ml penicillin-streptomycin and 0.1% Amphotericin B (Gibco). The SMC were cultured at 37ºC in a humidified environment of 5% CO 2 in air. The homogeneity of the SMC were assessed via immunocytochemistry using antibodies against smooth muscle actin (SMA), heavy chain of smooth muscle myosin (SMMHc), von Willibrand Factor (vWF) and CD 31 (DakoCytomation, Carpinteria, CA, USA).
Prior to the commencement of the study, the gelatinchitosan PU material was cut into pieces of 1 cm x 0.5 cm and sterilised in fresh 70% ethanol for 90 min. These pieces then underwent 2 thorough washes in sterile phosphate buffered saline (PBS; Gibco) for 30 min each and conditioned in DMEM overnight. The preconditioned materials were placed in fresh DMEM and SMC were seeded onto them at a density of 4 x 10 5 cells/cm 2 of material. The SMC were cultured for 1, 4 and 7 days, and then fixed in 10% neutral buffered formalin (Amber Scientific, Belmont, WA, Australia) for at least 12 h. SMC coverage on the gelatin-chitosan PU complex were visualised by en face immunochistochemistry using an antibody against SMA and analysed using an image analysis program, Image Pro Express ® Version 4.5.1.3 for Windows (Media Cybernetics Inc., San Diego, CA, USA).
Data were analysed using SPSS for Windows, Release 12.0.1 (SPSS Inc., Chicago, IL, USA). Comparison of SMC coverage across time course were analysed by one-way analysis of variance (ANOVA), choosing the Tukey's pairwise comparison option. A p value of 0.05 was considered statistically significant.
III. RESULTS
The surface morphology of gelatin-chitosan PU complex was examined using SEM. As shown in Figure 1 , the fibres were arranged randomly with the diameter ranging from 150 nm to 1200 nm and the average diameter of 680nm.
The isolated cells were spindle-shaped and elongated, and were aligned in parallel rows at confluence; a typical characteristic of SMC [3] . Immunocytochemistry demonstrated that these cells exhibited a uniform staining for SMC-specific markers, SMA and SMM-Hc while negative staining was observed for endothelial cell-specific marker, vWF. This indicated that the cells harvested were a homogenous population of SMC origin. Figure 2 showed that the SMC were elongated and had flattened out onto the surface of the gelating-chitosan PU complex. SMC that adhered to the material were initially rounded. However, by day 4 of culture, the majority of cells were elongated. As expected, an increase in cell coverage was observed across the experimental time course (p < 0.007, ANOVA). Figure 3 showed that the SMC coverage increased from 2.5 ± 0.2 at day 1 of culture to 7.84 ± 0.25 after 7 days in culture. 
IV. DISCUSSION
The ability of SMC to adhere and proliferate on the gelatinchitosan composite indicated that the biosynthetic material is biocompatible and also encouraged early cell attachment (Figure 2 ). The cells remained healthy throughout the experimental time course and there was no difference in the degree of cell death as compared to those grown in the tissue cultureware.
The sandwich-structured material discussed here was designed specifically for cardiovascular applications, namely for blood vessels and heart valve leaflets. The outer layer of gelatin-chitosan would provide the cells with a biological environment which encouraged cell attachment and growth. Studies have shown that endothelial cell adhesion were enhanced by gelatin and chitosan coating [4, 5] which is particularly applicable to heart valve leaflets as they comprise a monolayer of endothelial cells on the blood contacting surface. The role of the PU nanofibre mesh was to provide the required mechanical support, be it for leaflets or blood vessel. The random orientation of PU fibres in nanometre scale was aimed to mimic the natural extracellular matrix, thus, encouraging cells such as SMC to interact with the scaffold [6] . The pore size of the scaffold can be altered to tailor to specific cell types by changing the diameter of the nanofibres. Customised pore size is an important factor to consider as it has been shown that the optimum pore size varied depending on cell type, for example, fibroblast (approximately 5 -15 m) and those for bone regeneration (100 -350 m) [7, 8] .
As cells such as SMC migrates towards the PU nanofibre mesh, it is anticipated that the PU will exhibit good biocompatibility due to the wide usage of PU in medical applications [9] . Furthermore, Sanders et al. (2002) showed that PU fibres implanted in rats produced the least encapsulation compared to polyethylene and poly-L-lactic acid [10] .
In conclusion, creating biomaterials from nanofibres using electrospinning technique is an inexpensive and viable method. The materials can be easily mass produced and various types of polymeric nanofibres aside from PU (poly lactic acid and polycaprolactone) can be synthesised with the required diameter of fibres and pore size. The gelatin-chitosan PU complex has been demonstrated to be biocompatible, as shown by the SMC adherence and proliferation. The potential of this biosynthetic material will be further investigated by means of cell retention after flow in a 2D environment and progressing to cellular characterisation in a 3D scaffold of blood vessels and leaflets.
